Bsenexus Terminal Open in Bsenexus App →
BSE: 540719 SBILIFE NSE

SBI LIFE INSURANCE CO LTD (540719) — Latest Corporate Announcements

₹1,688.2 +₹7.40 (+0.44%)
Market Cap ₹1,69,395.54 Cr
P/E Ratio 64.98
52W Range ₹1652.9 – ₹2132

Corporate Actions & Regulatory Filings

SBI Life Insurance Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 SBI Life Insurance Company Ltd - 540719 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS SBI Life Insurance Company Ltd - 540719 - Intimation Under Regulation 30 Read With Para A Of Part A Of Schedule III Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Change in Directorate SBI Life Insurance Company Ltd - 540719 - Board Meeting Outcome for Outcome Of The Board Meeting Of The Company Held On September 22, 2026 SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation SBI Life Insurance Company Ltd - 540719 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation To consider and approve the financial results for the period ended June 30, 2026 To consider and approve the financial results for the period ended March 31, 2026 To consider and approve the financial results for the period ended December 31, 2025 To consider and approve the financial results for the period ended September 30, 2025 To consider and approve the financial results for the period ended Jun 30, 2025 To consider and approve the financial results for the period ended March 31, 2025 To consider and approve the financial results for the period ended December 31, 2024 To consider and approve the financial results for the period ended September 30, 2024 To consider and approve the financial results for the period ended Jun 30, 2024 To consider and approve the financial results for the period ended March 31, 2024

Financial Results (Quarterly & Annual)

Quarter / Period Meeting / Outcome Date Status Filing Details
Quarter Ended 30-Jun-2026 (Q1 FY27) 24-Jul-2026 Declared To consider and approve the financial results for the period ended June 30, 2026
Year Ended 31-Mar-2026 (Q4 FY26) 22-Apr-2026 Declared To consider and approve the financial results for the period ended March 31, 2026
Quarter Ended 31-Dec-2025 (Q3 FY26) 28-Jan-2026 Declared To consider and approve the financial results for the period ended December 31, 2025
Quarter Ended 30-Sep-2025 (Q2 FY26) 24-Oct-2025 Declared To consider and approve the financial results for the period ended September 30, 2025
Quarter Ended 30-Jun-2025 (Q1 FY26) 24-Jul-2025 Declared To consider and approve the financial results for the period ended Jun 30, 2025
Year Ended 31-Mar-2025 (Q4 FY25) 24-Apr-2025 Declared To consider and approve the financial results for the period ended March 31, 2025
Quarter Ended 31-Dec-2024 (Q3 FY25) 17-Jan-2025 Declared To consider and approve the financial results for the period ended December 31, 2024
Quarter Ended 30-Sep-2024 (Q2 FY25) 23-Oct-2024 Declared To consider and approve the financial results for the period ended September 30, 2024
Quarter Ended 30-Jun-2024 (Q1 FY25) 24-Jul-2024 Declared To consider and approve the financial results for the period ended Jun 30, 2024
Year Ended 31-Mar-2024 (Q4 FY24) 26-Apr-2024 Declared To consider and approve the financial results for the period ended March 31, 2024
Quarter Ended 31-Dec-2023 (Q3 FY24) 25-Jan-2024 Declared To consider and approve the financial results for the period ended December 31, 2023
Quarter Ended 30-Sep-2023 (Q2 FY24) 27-Oct-2023 Declared To consider and approve the financial results for the period ended September 30, 2023

Track Related Peer Equities

RELIANCE Track Reliance Industries Ltd Filings → TCS Track Tata Consultancy Services Ltd Filings → HDFCBANK Track HDFC Bank Ltd Filings → INFY Track Infosys Ltd Filings →

Related Research Guides & Regulatory Playbooks

SEBI LODR Regulation 30 Material Disclosures, Timelines & Filing Rules → Results Calendar Guide Earnings Dates, Board Notices & LODR Reg 33 → Shareholding Patterns Promoter Staking, Pledging & FII/DII Reg 31 → Insider Trading & PIT Trading Window Closures & Promoter Filings →

Frequently Asked Questions about SBI LIFE INSURANCE CO LTD BSE Disclosures

What is the latest BSE announcement by SBI LIFE INSURANCE CO LTD?

The latest BSE disclosure by SBI LIFE INSURANCE CO LTD (SBILIFE), filed on 12-Oct-2026 17:41:05, is: "SBI Life Insurance Company Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018". Bsenexus tracks every official filing for SBI LIFE INSURANCE CO LTD with AI-powered summaries on its announcements feed.

When is SBI LIFE INSURANCE CO LTD's next board meeting?

No upcoming board meeting is currently tracked for SBI LIFE INSURANCE CO LTD. Companies disclose meeting intimations under SEBI LODR, and scheduled dates appear on the Bsenexus Results Calendar.

When does SBI LIFE INSURANCE CO LTD declare quarterly results?

Under SEBI (LODR) Regulation 33, listed companies submit quarterly unaudited results within 45 days of the quarter ending, and annual audited figures within 60 days. SBI LIFE INSURANCE CO LTD's recent results history is tabulated above. Track scheduled board meetings on the Bsenexus Results Calendar.

Track SBI LIFE INSURANCE CO LTD Announcements on Bsenexus Live Terminal →